je.st
news
Biogen's Alzheimer's drug slows mental decline in early study
2015-03-20 19:38:02| Biotech - Topix.net
An experimental drug from Biogen Idec Inc became the first Alzheimer's treatment to significantly slow cognitive decline and reduce what is believed to be brain-destroying plaque in patients with early and mild forms of the disease, according to a small study likely to reignite hopes of a treatment. Alzheimer's affects 15 million people worldwide, a number that is expected to grow to 75 million by 2030 without effective treatments, likely costing billions of dollars year.
Tags: study
early
drug
mental
Category:Biotechnology and Pharmaceuticals